These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 11438908

  • 1. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
    Shanks GD, Kain KC, Keystone JS.
    Clin Infect Dis; 2001 Aug 01; 33(3):381-5. PubMed ID: 11438908
    [Abstract] [Full Text] [Related]

  • 2. Primaquine for prevention of malaria in travelers.
    Baird JK, Fryauff DJ, Hoffman SL.
    Clin Infect Dis; 2003 Dec 15; 37(12):1659-67. PubMed ID: 14689349
    [Abstract] [Full Text] [Related]

  • 3. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.
    Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ.
    Am J Trop Med Hyg; 2006 Sep 15; 75(3):402-15. PubMed ID: 16968913
    [Abstract] [Full Text] [Related]

  • 4. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
    Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, Horton J, Brueckner R.
    Clin Infect Dis; 2001 Dec 15; 33(12):1968-74. PubMed ID: 11700577
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ, Nasveld PE, Kitchener SJ, Kocisko DA, Edstein MD.
    Trans R Soc Trop Med Hyg; 2008 Nov 15; 102(11):1095-101. PubMed ID: 18541280
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS, Wilairatana P, Tang DB, Heppner DG, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S.
    Clin Infect Dis; 2004 Oct 15; 39(8):1095-103. PubMed ID: 15486831
    [Abstract] [Full Text] [Related]

  • 7. Primaquine therapy for malaria.
    Baird JK, Hoffman SL.
    Clin Infect Dis; 2004 Nov 01; 39(9):1336-45. PubMed ID: 15494911
    [Abstract] [Full Text] [Related]

  • 8. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens.
    Kain KC, Shanks GD, Keystone JS.
    Clin Infect Dis; 2001 Jul 15; 33(2):226-34. PubMed ID: 11418883
    [Abstract] [Full Text] [Related]

  • 9. Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force.
    Edstein MD, Walsh DS, Eamsila C, Sasiprapha T, Nasveld PE, Kitchener S, Rieckmann KH.
    Med Trop (Mars); 2001 Jul 15; 61(1):56-8. PubMed ID: 11584657
    [Abstract] [Full Text] [Related]

  • 10. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E, Regev-Yochay G.
    Clin Infect Dis; 1999 Dec 15; 29(6):1502-6. PubMed ID: 10585803
    [Abstract] [Full Text] [Related]

  • 11. Malaria chemoprophylaxis with tafenoquine: a randomised study.
    Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, Kremsner PG.
    Lancet; 2000 Jun 10; 355(9220):2041-5. PubMed ID: 10885356
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers.
    Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, Berman J.
    Clin Infect Dis; 1999 Jul 10; 29(1):199-201. PubMed ID: 10433587
    [Abstract] [Full Text] [Related]

  • 13. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C, Kozar MP, Pybus B, Sousa J, Berman J, Gettayacamin M, Im-erbsin R, Tungtaeng A, Ohrt C.
    J Parasitol; 2014 Oct 10; 100(5):671-3. PubMed ID: 24780070
    [Abstract] [Full Text] [Related]

  • 14. [New use of primaquine for malaria].
    Oliver M, Simon F, de Monbrison F, Beavogui AH, Pradines B, Ragot C, Moalic JL, Rapp C, Picot S.
    Med Mal Infect; 2008 Apr 10; 38(4):169-79. PubMed ID: 18395381
    [Abstract] [Full Text] [Related]

  • 15. Cost considerations of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis.
    Bryan JP.
    Am J Trop Med Hyg; 2006 Sep 10; 75(3):416-20. PubMed ID: 16968914
    [Abstract] [Full Text] [Related]

  • 16. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.
    Baird JK, Lacy MD, Basri H, Barcus MJ, Maguire JD, Bangs MJ, Gramzinski R, Sismadi P, Krisin, Ling J, Wiady I, Kusumaningsih M, Jones TR, Fryauff DJ, Hoffman SL, United States Naval Medical Research Unit 2 Clinical Trials Team.
    Clin Infect Dis; 2001 Dec 15; 33(12):1990-7. PubMed ID: 11712091
    [Abstract] [Full Text] [Related]

  • 17. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S, Nasveld P, Edstein MD.
    Am J Trop Med Hyg; 2007 Mar 15; 76(3):494-6. PubMed ID: 17360873
    [Abstract] [Full Text] [Related]

  • 18. The impact of Malarone and primaquine on psychomotor performance.
    Paul MA, McCarthy AE, Gibson N, Kenny G, Cook T, Gray G.
    Aviat Space Environ Med; 2003 Jul 15; 74(7):738-45. PubMed ID: 12862328
    [Abstract] [Full Text] [Related]

  • 19. New strategies for the prevention of malaria in travelers.
    Chen LH, Keystone JS.
    Infect Dis Clin North Am; 2005 Mar 15; 19(1):185-210. PubMed ID: 15701554
    [Abstract] [Full Text] [Related]

  • 20. [Malaria chemoprophylaxis in traveling children].
    Minodier P, Noël G, Blanc P, Tsaregorodtseva N, Retornaz K, Garnier JM.
    Arch Pediatr; 2005 Jan 15; 12(1):53-8. PubMed ID: 15653056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.